Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn’s disease patients with prior failure to anti‐TNF treatmentVince Biemans, Mark Löwenberg, Nanne K.H. de Boer et al.|Alimentary Pharmacology & Therapeutics|2020Cited by 129
Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registryVince Biemans, Jasmijn A M Sleutjes, Annemarie C. de Vries et al.|Alimentary Pharmacology & Therapeutics|2020Cited by 87
In-vitro antimicrobial activity of bark extracts of an ethnic plant Zanthoxylum armatum DC. against selected human pathogens in Uttarakhand Himalaya.Nidhi Srivastava, Arun Bhatt, Anup Kainthola|International Journal of Herbal Medicine|2013Cited by 14